Clinical Trial Update: Safety and Efficacy of Topical Moxifloxacin for Prevention of Post-Traumatic Endophthalmitis: Randomized Controlled Clinical Trial [Phase 2]

View source ↗

Summary

Phase 2 randomized trial evaluating topical moxifloxacin for prevention of post-traumatic endophthalmitis after open globe injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endophthalmitis
• Open Globe Injury

Drugs mentioned

• Moxifloxacin (moxifloxacin)

Snippet

Sponsor: University of Campinas, Brazil | Conditions: Endophthalmitis, Open Globe Injury | Phase 2 | Status: UNKNOWN